Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines

Details for Australian Patent Application No. 2003208539 (hide)

Owner Institut Pasteur Veterinary Laboratories Agency

Inventors Garnier, Thierry; Eiglmeier, Karin; Brosch, Roland; Cole, Stewart; Gordon, Stephen

Agent Freehills

Pub. Number AU-B-2003208539

PCT Number PCT/IB03/00986

PCT Pub. Number WO2003/070981

Priority 02290458.5 25.02.02 EP

Filing date 25 February 2003

Wipo publication date 9 September 2003

Acceptance publication date 20 November 2008

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/04 (2006.01) Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 31/06 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/35 (2006.01) Peptides having more than 20 amino acids

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

C12Q 1/04 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Determining presence or kind of micro-organism

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 02290458.5 25.02.02 EP

9 October 2003 Application Open to Public Inspection

  Published as AU-B-2003208539

20 November 2008 Application Accepted

  Published as AU-B-2003208539

19 March 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003208540-CHECK ANTI-FRAUD SECURITY SYSTEM

2003208538-Amino acids with affinity for the alpha2-delta-protein